Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 14, 2014
Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
Livnat Brill, Lotem Goldberg, Arnon Karni, et al.
Plos One
|
July 7, 2015
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases
Keren Turjeman, Yaelle Bavli, Pablo Kizelsztein, et al.
Oncotarget
|
May 8, 2018
Androgen receptor: a potential therapeutic target for glioblastoma
Nomi Zalcman, Tamar Canello, Haim Ovadia, et al.
Annals of the New York Academy of Sciences
|
February 1, 2005
New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists
Nigel H Greig, Mark P Mattson, Tracyann Perry, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
April 8, 2014
Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD
Michal Mizrahi, Yael Friedman-Levi, Liraz Larush, et al.
Brain Research
|
March 17, 2011
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
Athanasios Lourbopoulos, Nikolaos Grigoriadis, Roza Lagoudaki, et al.
Plos One
|
August 31, 2013
Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria
Judith H Waknine-Grinberg, Simcha Even-Chen, Jasmine Avichzer, et al.
JACS Au
|
January 3, 2022
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis
Chaim Gilon, Michal Klazas, Adi Lahiani, et al.
Journal of Autoimmunity
|
August 14, 2021
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A
Maayan Hemed-Shaked, Mary K Cowman, Jin Ryoun Kim, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 14, 2014
Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
Livnat Brill, Lotem Goldberg, Arnon Karni, et al.
Plos One
|
July 7, 2015
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases
Keren Turjeman, Yaelle Bavli, Pablo Kizelsztein, et al.
Oncotarget
|
May 8, 2018
Androgen receptor: a potential therapeutic target for glioblastoma
Nomi Zalcman, Tamar Canello, Haim Ovadia, et al.
Annals of the New York Academy of Sciences
|
February 1, 2005
New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists
Nigel H Greig, Mark P Mattson, Tracyann Perry, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
April 8, 2014
Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD
Michal Mizrahi, Yael Friedman-Levi, Liraz Larush, et al.
Brain Research
|
March 17, 2011
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
Athanasios Lourbopoulos, Nikolaos Grigoriadis, Roza Lagoudaki, et al.
Plos One
|
August 31, 2013
Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria
Judith H Waknine-Grinberg, Simcha Even-Chen, Jasmine Avichzer, et al.
JACS Au
|
January 3, 2022
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis
Chaim Gilon, Michal Klazas, Adi Lahiani, et al.
Journal of Autoimmunity
|
August 14, 2021
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A
Maayan Hemed-Shaked, Mary K Cowman, Jin Ryoun Kim, et al.
Page
of 5